SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending sharply following FDA approval of BYSANTI for bipolar I disorder and schizophrenia, fueling community excitement for substantial upside, a potential short squeeze, and speculation that the approval strengthens the case for future pipeline successes and a possible acquisition.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending following a sector-wide sell-off driven by fears that Anthropic's new Claude Code Security tool will disrupt traditional cybersecurity, sparking intense community debate over CRWD's valuation versus its distinct role in endpoint and cloud protection against evolving AI threats.

JFrog Ltd. engages in the provision of an end-to-end, hybrid, universal development operations platform that powers and controls the software supply chain, which enables organizations to continuously and securely deliver software updates across any system. It operates through the following geographical segments: United States, Israel, India, and Rest of World. The firm is also involved in creating software delivered without friction from developer to device. The company was founded by Frederic Simon, Shlomi Ben Haim, and Yoav Landman in 2008 and is headquartered in Sunnyvale, CA.

JFrog Ltd

JFrog ($FROG) is trending after a substantial stock plunge, driven by market concerns that Anthropic's Claude Code Security could disrupt its DevSecOps business; however, community discussion is divided, with many viewing the sharp sell-off as an overreaction and a potential buying opportunity.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending due to its robust cross-chain "Intents" technology enabling seamless interoperability with major ecosystems like Starknet on Solana, and its enhanced AI integrations including a partnership with NVIDIA. With a Grayscale Trust filing signaling institutional interest and a recent reduction in token inflation, the community views NEAR as a strategic long-term hold despite current market volatility.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as community discussion focuses on its strategic exclusion from China's national drug list, aiming to preserve pricing power, while investors keenly await a pending U.S. Supreme Court decision on its patent infringement case. This coincides with anticipated positive financial results and ongoing speculation about a potential acquisition as the company positions for a turnaround.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy (SWEAT CRYPTO) is trending as its community discusses the unique move-to-earn utility and staking potential, despite acknowledging its current low prices and significant year-over-year drops. Many investors are expressing long-term conviction, anticipating the token will "rise one day" and often linking its prospects to the NEAR ecosystem.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl Capital is trending due to community debate over reported challenges in financing a major AI data center and a strategic shift in capital redemption for a retail private credit fund, fueling broader liquidity concerns in the sector while attracting value investors.

Santacruz Silver Mining Ltd. engages in the acquisition, exploration, and development of mineral properties. It operates through the following segments: Bolivar, Porco, Caballo Blanco Group, San Lucas Group, Zimapan, and Corporate and Other. The Bolivar segment focuses on mine and processing plants. The Porco segment is invovled in mine and processing plants. The Caballo Blanco Group segment includes the Tres Amigos, Colquechaquita mines and the Don Diego processing plant. The San Lucas Group segment refers to Reserva mine and San Lucas feed sourcing business. The Zimapan segment consists of mine and processing plant. The company was founded on January 24, 2011 and is headquartered in Vancouver, Canada.

Santacruz Silver Mining Ltd

Santacruz Silver Mining Ltd.

Santacruz Silver Mining Ltd. (SCZMF) is trending following its recent Nasdaq uplisting and strong operational performance, which has prompted a research firm to significantly raise its price target. The community is actively discussing the stock's perceived undervaluation and substantial profit potential, driven by a bullish outlook for silver prices and anticipation of increased institutional interest.

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is trending due to an analyst upgrade cycle and keen anticipation for its upcoming earnings, as investors debate its robust e-commerce and fintech growth against potential margin pressures. Community discussion also highlights speculative interest in the company's expanding logistics network and emerging market opportunities across Latin America, including Venezuela.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Anticipation is building around potential tariff reversals on key inputs like Italian tomatoes and steel, which the community believes could provide a significant margin boost and re-rate Campbell Soup Co., especially as the broader consumer staples sector grapples with consumer demand concerns from peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 10.2% - Here's Why

Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 10.2% - Here's Why...

45,205 Shares in Stoke Therapeutics, Inc. $STOK Acquired by Principal Financial Group Inc.

Principal Financial Group Inc. bought a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) in the third quarter, according to its most recent 13F filing with the...

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine and has a lead investigational...

Stoke Therapeutics spotlights durable Dravet gains, Phase 3 timeline, and new ADOA program at summit

Stoke Therapeutics (NASDAQ:STOK) used its presentation at the Guggenheim Emerging Outlook Biotech Summit 2026 to highlight long-term clinical findings for its lead program in Dravet syndrome, outline...

Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine, today announced that the first patient...

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) has been given an average rating of "Moderate Buy" by the eleven brokerages that are currently covering the stock, Marketbeat Ratings reports...

Guggenheim Upgrades Stoke Therapeutics (NASDAQ:STOK) to "Strong-Buy"

Guggenheim upgraded shares of Stoke Therapeutics to a "strong-buy" rating in a report on Thursday...

Penserra Capital Management LLC Acquires New Position in Stoke Therapeutics, Inc. $STOK

Penserra Capital Management LLC bought a new position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC...

Stoke Therapeutics (NASDAQ:STOK) Trading 6.2% Higher - Here's What Happened

Stoke Therapeutics (NASDAQ:STOK) Trading Up 6.2% - Here's What Happened...

Stoke Therapeutics, Inc. $STOK is Skorpios Trust's Largest Position

Skorpios Trust lowered its holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) by 30.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The...

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

STOK
Stoke Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest STOK News

STOKStoke Therapeutics Inc